Medico Remedies Limited (BOM:540937)

Market Cap	4.44B
Revenue (ttm)	1.72B
Net Income (ttm)	113.47M
Shares Out	82.98M
EPS (ttm)	1.36
PE Ratio	39.22
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	35,439
Average Volume	11,263
Open	43.93
Previous Close	44.70
Day's Range	43.93 - 49.17
52-Week Range	35.00 - 79.78
Beta	0.23
RSI	60.55
Earnings Date	Feb 14, 2026

About Medico Remedies

Medico Remedies Limited develops, manufactures, and sells pharmaceutical and nutraceutical products in India. The company offers antibiotics and anti-infectives; beta-lactams-penicillins and cephalosporins; antifungals; vitamins and supplements; cardiovascular products; antipyretic, analgesic, and NSAIDs medicines; antacid and anti-ulcer drugs; antidepressants, antipsychotics, and anti-epileptics; antimalarials; dry syrups; ointments and creams; anti-diabetics; syrups; and miscellaneous products, as well as diuretics, antireterovirals, and ster...

• Industry: Pharmaceutical Preparations
• Founded: 1994
• Employees: 213
• Stock Exchange: Bombay Stock Exchange
• Ticker Symbol: 540937

Financial Performance

In 2024, Medico Remedies's revenue was 1.51 billion, an increase of 4.15% compared to the previous year's 1.45 billion. Earnings were 100.93 million, an increase of 21.74%.